Jordano Brito‐Moreira

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Theresa R. Bomfim, Letícia Forny‐Germano, Luciana B. Sathler et al. · Journal of Clinical Investigation · 2012 · 812 citations · Full text

Synaptic Transmission, Synaptic Signaling, Insulin Signaling +28

TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys

Mychael V. Lourenco, Julia R. Clarke, Rudimar Luiz Frozza et al. · Cell Metabolism · 2013 · 407 citations · Full text

Neurodegenerative Diseases, β-Amyloid Oligomers, Alzheimer's Disease +13

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

André F. Batista, Letícia Forny‐Germano, Julia R. Clarke et al. · The Journal of Pathology · 2018 · 236 citations · Full text

Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates

Letícia Forny‐Germano, Natalia M. Lyra e Silva, André F. Batista et al. · Journal of Neuroscience · 2014 · 225 citations · Full text

Synaptic Transmission, Pathology, Neurochemical Biomarkers +19

<i>N</i>‐Methyl‐<scp>d</scp>‐aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid‐β peptide oligomers

Helena Decker, Sofia Jürgensen, Martín F. Adrover et al. · Journal of Neurochemistry · 2010 · 161 citations · Full text